← All Climb Bio, INC filings

Climb Bio, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
CLYM
Climb Bio, INC
SCHEDULE: FMR LLC Discloses 11.9% Stake in Climb Bio Inc.
FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 11.9% in Climb Bio Inc. as of June 30, 2026.
NASDAQ
CLYM
Climb Bio, INC
SCHEDULE: Pontifax Funds Disclose 7.7% Stake in Climb Bio
Investment funds managed by Pontifax have reported a 7.7% beneficial ownership stake in Climb Bio, Inc. common stock.
NASDAQ
CLYM
Climb Bio, INC
SCHEDULE 13G/A: BML Investment Partners Divests Entire Stake in Climb Bio, Inc.
BML Investment Partners, L.P. and Leonard Braden Michael have reported a complete divestment of their beneficial ownership in Climb Bio, Inc., reducing their stake to 0% of the common stock.